Skip to main content
. 2022 Aug 1;13(8):895–920. doi: 10.1039/d2md00081d

The targets for analgesics.

Target Target location Example Challenges
Opioid CNS Morphine Abuse potential
Fentanyl
Inhibition of prostaglandin synthesis (NSAID) Peripheral tissue Aspirin Limited efficacy
Diclofenac GI and CV adverse effects
Loxoprofen
Gabapentinoid (α2δ ligand) CNS Gabapentin CNS adverse effects
Pregabalin
Mirogabalin
VGSC inhibitor PNS and CNS Lidocaine CNS and CV adverse effects
Mexiletine